Kyungho Choi Selected Research

Therapeutics

4/2016	Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy.
1/2015	Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma.
6/2012	Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.
12/2011	An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyungho Choi Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 01/2006
8	Obesity 10/2023 - 07/2015
4	Chronic Renal Insufficiency 12/2023 - 10/2019
4	Phototoxic Dermatitis (Phototoxicity) 04/2010 - 01/2008
3	Diabetes Mellitus 01/2022 - 01/2021
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2017
3	Neuromyelitis Optica (Devic's Disease) 05/2020 - 05/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 04/2010
2	Body Weight (Weight, Body) 12/2023 - 03/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 01/2018
2	Pregnancy Complications 03/2022 - 10/2018
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2022
2	Albuminuria 10/2020 - 01/2020
2	Leiomyoma (Uterine Fibroids) 10/2020 - 01/2020
2	Multiple Sclerosis 05/2020 - 05/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Insulin Resistance 10/2019 - 01/2018
2	Chromosome Breakage 05/2012 - 06/2011
1	Atrophy 12/2023
1	Fibrosis (Cirrhosis) 12/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Prehypertension 01/2023
1	Allergic Rhinitis 04/2022
1	Atopic Dermatitis (Atopic Eczema) 04/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fever (Fevers) 01/2021
1	Leukemia 01/2020
1	Dyslipidemias (Dyslipidemia) 05/2019
1	Hypothyroidism 04/2019
1	Neurodevelopmental Disorders 03/2017

Drug/Important Bio-Agent (IBA)

6	Diethylhexyl Phthalate (DEHP)IBA 12/2023 - 03/2015
5	ORALIT (ORS)IBA 01/2024 - 01/2020
5	CadmiumIBA 01/2024 - 01/2020
5	ParabensIBA 04/2022 - 01/2020
4	Heavy MetalsIBA 01/2024 - 01/2022
4	phthalic acid (phthalate)IBA 12/2023 - 10/2019
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2018
4	bisphenol AIBA 01/2021 - 01/2018
3	LeptinIBA 10/2019 - 07/2015
2	MercuryIBA 01/2024 - 01/2022
2	LipidsIBA 10/2023 - 05/2019
2	AlbuminsIBA 01/2023 - 01/2020
2	CreatinineIBA 01/2023 - 01/2020
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2023 - 01/2022
2	Persistent Organic PollutantsIBA 09/2022 - 10/2018
2	EnzymesIBA 01/2022 - 01/2021
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 10/2019
2	Volatile Organic CompoundsIBA 01/2022 - 01/2020
2	ethyl-p-hydroxybenzoateIBA 01/2021 - 01/2020
2	OrganophosphatesIBA 10/2020 - 10/2019
2	EstersIBA 10/2020 - 10/2019
2	Immunoglobulin G (IgG)IBA 05/2020 - 05/2012
2	AdipokinesIBA 10/2019 - 07/2015
2	Insulin (Novolin)FDA Link 10/2019 - 01/2018
2	AdiponectinIBA 10/2019 - 07/2015
2	Thyroid HormonesIBA 03/2017 - 09/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 03/2013 - 06/2012
2	Sulfathiazole FDA Link 01/2009 - 01/2008
1	MetalsIBA 01/2024
1	Organic Chemicals (Chemicals, Organic)IBA 01/2023
1	mono(2-ethyl-5-hydroxyhexyl) phthalateIBA 01/2023
1	Polychlorinated Biphenyls (PCBs)IBA 09/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	2-naphtholIBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 12/2021
1	PhenolsIBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	mono-benzyl phthalateIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	Ointments (Pastes)IBA 01/2021
1	PlasticizersIBA 10/2020
1	Endocrine DisruptorsIBA 10/2020
1	A-factor (Streptomyces)IBA 10/2020
1	tris(1,3-dichloroisopropyl) phosphateIBA 10/2020
1	Phosphates (Orthophosphate)IBA 10/2020
1	terephthalic acid (terephthalate)IBA 10/2020
1	tris(2-butoxyethyl) phosphateIBA 10/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	CosmeticsIBA 01/2020
1	Minor Histocompatibility AntigensIBA 01/2020
1	2,5-dimethylfuranIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	bis(4-hydroxyphenyl)sulfoneIBA 10/2019
1	mono-isobutyl phthalateIBA 10/2019
1	Gemfibrozil (Lopid)FDA LinkGeneric 05/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2019
1	Iodide Peroxidase (Deiodinase)IBA 04/2019
1	Corticotropin-Releasing HormoneIBA 04/2019
1	Thyroglobulin FDA Link 04/2019
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 03/2018
1	Aquaporins (Water Channels)IBA 04/2017

Therapy/Procedure

4	Therapeutics 04/2016 - 12/2011
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021
1	Cesarean Section (Caesarean Section) 04/2017